만성 정맥 폐색증 치료 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Chronic Venous Occlusions Treatment Market size is expected to reach USD 12.62 Billion in 2034 from USD 7.84 Billion (2025) growing at a CAGR of 5.43% during 2026-2034.

The Global Chronic Venous Occlusions Treatment Market is experiencing steady growth due to the rising prevalence of deep vein thrombosis, post-thrombotic syndrome, and other venous disorders. Increasing aging populations and sedentary lifestyles have contributed significantly to the burden of chronic venous occlusions worldwide. Advancements in minimally invasive endovascular procedures, including catheter-directed thrombolysis and stent placement, are enhancing patient outcomes and expanding treatment adoption across developed and emerging economies.

Key growth drivers include growing awareness about venous health, improved diagnostic imaging technologies, and expanding healthcare infrastructure in developing regions. The demand for effective, less invasive treatment options is increasing as patients prefer shorter hospital stays and faster recovery times. Additionally, favorable reimbursement policies in several countries are encouraging hospitals and specialty clinics to adopt advanced venous intervention devices and therapies.

Looking ahead, the market is expected to benefit from technological innovations such as drug-eluting stents and image-guided intervention systems. Increasing clinical research and collaborations between medical device companies and healthcare providers will likely improve procedural success rates. As early diagnosis becomes more common and patient awareness rises, the market is projected to witness sustained expansion over the forecast period.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product

• Devices
• Drugs

By Application

• Varicose veins

By End-use

• Hospitals
• Ambulatory Surgical Centers
• Other End-Users

COMPANIES PROFILED

• 3M Company, , Bayer AG, Boston Scientific Corporation, Bristol Myers Squibb, Candela, ConvaTec Inc, Fotona, Julius Zorn GmbH, Leucadia Pharmaceuticals Hikma, Lumenis Ltd, Medi GmbH Co KG, Medtronic plc, Merz Pharma, Pfizer Inc, Sanofi
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET: BY PRODUCT 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product
• 4.2. Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Drugs Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Varicose veins Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET: BY END-USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End-use
• 6.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Other End-Users Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product
  • 7.2.2 By Application
  • 7.2.3 By End-use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product
  • 7.3.2 By Application
  • 7.3.3 By End-use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product
  • 7.4.2 By Application
  • 7.4.3 By End-use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product
  • 7.5.2 By Application
  • 7.5.3 By End-use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product
  • 7.6.2 By Application
  • 7.6.3 By End-use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL CHRONIC VENOUS OCCLUSIONS TREATMENT INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Bayer AG
  • 9.2.2 Boston Scientific Corporation
  • 9.2.3 Bristol Myers Squibb
  • 9.2.4 Candela
  • 9.2.5 ConvaTec Inc
  • 9.2.6 Fotona
  • 9.2.7 Julius Zorn GmbH
  • 9.2.8 Leucadia Pharmaceuticals (Hikma)
  • 9.2.9 Lumenis Ltd
  • 9.2.10 Medi GmbH & Co. KG
  • 9.2.11 Medtronic Plc
  • 9.2.12 Merz Pharma
  • 9.2.13 Pfizer Inc
  • 9.2.14 Sanofi